CClinicalTrials.gg
CompletedNCT01412723Updated Apr 11, 2012

Ferrous Sulfate Versus Iron Amino Acid Chelate

A Phase 3 interventional study of Ferrous sulfate as dietary supplementation and Iron amino acid chelated as dietary supplementation in Iron Deficiency, sponsored by CES University. Completed at 1 site in Colombia. Open to participants aged 2 Years to 5 Years. Per ClinicalTrials.gov, last updated 2012-04-11.

Sponsored by CES University · Phase 3, Interventional, and Supportive care

Phase
Phase 3
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
2 Years to 5 Years
Sex
All
01

Study summary

Iron deficiency and depleted levels of iron are the most prevalent nutritional deficiency and the leading cause of anemia in the world; this can occur at any age, but preschool children are at particular risk of developing it. This condition may cause serious repercussions for life, being a public health threat of considerable importance worldwide.

Food fortification is considered the most effective solution to counter this situation, because it can help more people than other solutions. It is going to carry out a community trial to compare the efficacy of ferrous sulfate with respect to iron amino acid chelate as a dietary supplement in preschool children of Medellin with depleted levels of iron; in terms of increasing ferritin levels in blood and maintain hemoglobin levels. It is hypothesized that at the end of the study the effect of milk fortified with iron amino acid chelate won't be less than the effect of fortified with ferrous sulfate.

It is hoped that the results may contribute, albeit indirectly, to improve the health status of children with depleted levels of iron whom consume iron-fortified products.

02

Conditions studied

  • Iron Deficiency

Keywords

  • Iron Deficiency
  • Child, Preschool
  • Dietary Iron
  • Ferrous sulfate
  • Bis-glycino iron II
03

In context

Anemia, Iron-Deficiency

644 studies on the registry are indexed under Anemia, Iron-Deficiency; 105 are open to participants now.

This study's enrollment of 64 is below the median of 100 across 503 interventional studies indexed under Anemia, Iron-Deficiency.

Browse Anemia, Iron-Deficiency studies →

Lead sponsor

CES University is the lead sponsor of 28 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Children who

  • Belong to institute FAN in Medellín
  • Attend full time to institute FAN (eight hours)
  • Have 2 to 5 years inclusive
  • Submit depleted levels of iron (ferritin level equal to or less than 24 mg/L)

Exclusion criteria

Exclusion Criteria:

Children who

  • Submit anemia (hemoglobin level equal to or less than 11 g/dL)
  • Have not stool analysis before intervention
05

Study design

Phase
Phase 3
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
64 participants (actual)

Study arms

  • Active comparator
    Ferrous sulphate

    Preschool children with depleted levels of iron enrolled in FAN Foundation of Medellin, which will be supplied with ferrous sulfate-fortified milk

    Other: Ferrous sulfate as dietary supplementation

  • Experimental
    Iron Amino acid chelate

    Preschool children with depleted levels of iron enrolled in FAN Foundation of Medellin , which will be supplied with iron amino acid chelate-fortified milk

    Other: Iron amino acid chelated as dietary supplementation

Interventions

  • OtherFerrous sulfate as dietary supplementation

    Ferrous sulfate as dietary supplementation

  • OtherIron amino acid chelated as dietary supplementation

    Iron amino acid chelated as dietary supplementation

06

What researchers measure

Primary outcomes

  1. Ferritin

    The Ferritin level in blood will be measured at the beginning of the study as one of the most important inclusion criteria. This also will be the base line of the study. After that randomization will be carried out and after two months (time frame which ferrous sulfate or iron aminoacid chelate would increase ferritin level in blood) ferritin level will be measured again as the primary outcome measure.

    Time frame: Up to 8 weeks

Secondary outcomes

  1. Hemoglobin

    The Hemoglobin level in blood will be measured at the beginning of the study as one of the most important exclusion criteria. After that randomization will be carried out and after two months (time frame which ferrous sulfate or iron aminoacid chelate would increase ferritin level in blood) hemoglobin level will be measured again as one of secundary outcome measure. The hypothesis is that the hemoglobin level won't decrease

    Time frame: Up to 8 weeks

  2. Infection

    Daily written report of the caregiver during the intervention

    Time frame: Daily. During 2 months of intervention

  3. Adverse reaction

    The caregiver recorded daily if the child had an adverse reaction such as abdominal pain, nausea, vomiting, constipation, diarrhea, darkening of feces, and disgust for food.

    Time frame: Daily. During 2 months of intervention

07

Study locations

1 site
  • Universidad CES
    Medellin, Antioquia, Colombia
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 11, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01412723
Lead sponsor
CES University
Collaborators
Nutreva S.A.S., Foundation Child Care - FAN
Responsible party
Jose María Maya Mejía (Dean, CES University) — Principal investigator
First posted
Aug 9, 2011
Start date
Oct 2011
Primary completion
Dec 2011
Completion
Apr 2012
Last update
Apr 11, 2012

Study contacts

Ana M Herrera, PhD en Patología
study director · CES University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion